$0.43
1.39% today
NYSE, Oct 15, 07:19 pm CET
ISIN
US81727U1051
Symbol
SENS

Senseonics Stock price

$0.44
-0.01 2.63% 1M
-0.18 28.56% 6M
-0.08 15.93% YTD
+0.08 21.55% 1Y
-0.69 61.06% 3Y
+0.05 11.65% 5Y
-2.81 86.46% 10Y
-2.81 86.46% 20Y
NYSE, Closing price Tue, Oct 14 2025
+0.02 4.96%
ISIN
US81727U1051
Symbol
SENS

Key metrics

Basic
Market capitalization
$358.5m
Enterprise Value
$267.3m
Net debt
positive
Cash
$126.4m
Shares outstanding
814.6m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
14.1 | 9.7
EV/Sales
10.5 | 7.3
EV/FCF
negative
P/B
3.8
Financial Health
Equity Ratio
21.0%
Return on Equity
-372.6%
ROCE
-47.9%
ROIC
-
Debt/Equity
0.4
Financials (TTM | estimate)
Revenue
$25.5m | $36.8m
EBITDA
$-63.2m | $-64.6m
EBIT
$-64.9m | $-58.5m
Net Income
$-68.2m | $-62.9m
Free Cash Flow
$-54.8m
Growth (TTM | estimate)
Revenue
6.0% | 63.7%
EBITDA
12.7% | 12.0%
EBIT
12.0% | 21.8%
Net Income
15.2% | 20.0%
Free Cash Flow
17.5%
Margin (TTM | estimate)
Gross
17.8%
EBITDA
-248.2% | -175.6%
EBIT
-255.0%
Net
-267.9% | -171.1%
Free Cash Flow
-215.2%
More
EPS
$-0.1
FCF per Share
$-0.1
Short interest
6.4%
Employees
117
Rev per Employee
$190.0k
Show more

Is Senseonics a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,013 stocks worldwide.

Senseonics Stock Analysis

Unlock Scores for Free

Analyst Opinions

13 Analysts have issued a Senseonics forecast:

10x Buy
77%
2x Hold
15%
1x Sell
8%

Analyst Opinions

13 Analysts have issued a Senseonics forecast:

Buy
77%
Hold
15%
Sell
8%

Financial data from Senseonics

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
25 25
6% 6%
100%
- Direct Costs 21 21
1% 1%
82%
4.53 4.53
57% 57%
18%
- Selling and Administrative Expenses 35 35
8% 8%
136%
- Research and Development Expense 35 35
22% 22%
137%
-63 -63
13% 13%
-248%
- Depreciation and Amortization 1.72 1.72
28% 28%
7%
EBIT (Operating Income) EBIT -65 -65
12% 12%
-255%
Net Profit -68 -68
15% 15%
-268%

In millions USD.

Don't miss a Thing! We will send you all news about Senseonics directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Senseonics Stock News

Neutral
GlobeNewsWire
9 days ago
Preliminary unaudited revenue of $8.1 million for Q3 2025 Generated record quarterly new patient starts in Q3 2025 Established reverse stock split ratio of 1:20, anticipated to be effective October 17, 2025 GERMANTOWN, Md., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and manufacturing of long-term, imp...
Neutral
Seeking Alpha
about one month ago
Senseonics Holdings, Inc. (NYSE:SENS ) Eversense 365 Commercial Update Conference Company Participants Tim Goodnow - President, CEO & Director Frederick Sullivan - CFO, Secretary & Treasurer Conference Call Participants Jeremy Feffer - Lifesci Advisors, LLC Brian Hansen - Ascensia Diabetes Care Us Inc. Matthew Miksic - Barclays Bank PLC, Research Division Anthony Petrone - Mizuho Securities USA...
Neutral
Business Wire
about one month ago
TOKYO--(BUSINESS WIRE)--PHC Holdings Corporation (President, Representative Director and CEO: Kyoko Deguchi, TSE: 6523) and its subsidiary Ascensia Diabetes Care, a global diabetes care company, today announced that Ascensia has signed a memorandum of understanding to transfer the commercial operations for Eversense® Continuous Glucose Monitoring (CGM) systems to Eversense maker Senseonics Hold...
More Senseonics News

Company Profile

Senseonics Holdings, Inc. engages in the design, development, and commercialization of an implantable continuous glucose monitoring system for people with diabetes. Its primary product is the brand Eversense, a glucose monitoring device which includes sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.

Head office United States
CEO Timothy Goodnow
Employees 117
Founded 2014
Website www.senseonics.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today